Life sciences software & AI news

Showing 1000+ results

Sep 10, 2026

AINN-P1: Small Model, Big Intelligence

AINN-P1: Small Model, Big IntelligenceHow does a 167M-parameter protein foundation model outperform a 650M general-purpose model on the tasks that matter?Ainnocence Inc.,an AI-driven drug discovery company, announced new results for AINN-P1, apurpose-built protein foundation model designed to deliver efficient andtransferable predictions for protein engineering and biologics discovery.AINN-P1 takes a sequence-first approach,generating protein representations directly from amino acid sequences wi

A petri dish with antimicrobial cultures in a lab setting.

Sep 10, 2026

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Researchers are leveraging AI tools like Codex and ChatGPT to expedite the discovery of new antimicrobial molecules, addressing the urgent challenge of drug-resistant infections.César de la Fuente and his team are at the forefront of this innovative approach, focusing on the genetic codes of both living and extinct organisms to identify potential antimicrobial compounds. The urgency of their work is underscored by alarming statistics: antimicrobial resistance is responsible for millions of death

Sep 10, 2026

Press release

Response Media launches RE:HEALTH to Address Pharma's $300 Billion Adherence Blind Spot¹

New health and life sciences practice debuts AdherenceIQ, an AI-powered platform that predicts patient adherence riskATLANTA, Sept. 10, 2026 /PRNewswire/ -- Medication nonadherence costs the U.S. healthcare system as much as $300 billion annually. Despite significant investments in awareness, patient acquisition, and new prescription generation, life sciences companies struggle to identify which patients will start/discontinue therapy and understand the emotional barriers driving those decisions

A test tube with a colorful chemical compound in a dimly lit lab

Sep 10, 2026

Novalix and OpenBench partner to deliver AI-validated hit series on fee-for-success basis

Novalix and OpenBench have announced a strategic partnership aimed at revolutionizing the drug discovery process by offering AI-validated chemical hit series through a fee-for-success model.In this collaboration, OpenBench will initially screen vast libraries of compounds, identifying and synthesizing the most promising candidates. These hits will then be handed over to Novalix, which will utilize its in vitro screening capabilities to refine these candidates into actionable starting points for

Sep 10, 2026

Press release

Trusted Health Collaborates to Bring CareCast Workforce Demand Forecasting to Health Systems

Mayo Clinic's CareCast will be integrated into Trusted Works, laying the foundation for proactive staffing and clinician-centered schedulingSAN FRANCISCO, Sept. 10, 2026 /PRNewswire/ -- Trusted Health, a healthcare workforce technology company, today announced a collaboration to bring Mayo Clinic's CareCast workforce demand forecasting technology to hospitals and health systems through Trusted Works.Developed by Mayo Clinic, CareCast uses historical staffing, patient volume trends, and operation

Sep 10, 2026

Press release

Revenue Cycle Management Market worth $132.06 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 10, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Revenue Cycle Management (RCM) Market is projected to reach USD 132.06 billion by 2031 from USD 73.61 billion in 2026, at a CAGR of 12.4% during the forecast period.Browse 436 market data Tables and 50 Figures spread through 378 Pages and in-depth TOC on "Revenue Cycle Management (RCM) Market - Global Forecast to 2031"Revenue Cycle Management Market Size & Forecast:Market Size Available for Years: 2026–20

Sep 10, 2026

Press release

Healthcare Success Partners with Inlets.ai to Prepare Health Systems for AI-Driven Patient Discovery

Strategic Partnership Provides Hospitals & Multi-location Health Systems with Continuous AI Visibility & Optimization as Patient Search Shifts Beyond Traditional SearchTUSTIN, Calif., Sept. 10, 2026 /PRNewswire/ -- Healthcare Success today announced a strategic partnership with Inlets.ai empowering health systems, hospitals, multi-provider organizations, and multi-location healthcare organizations to protect market share and accurately represent their brands as patient discovery rapidly

Sep 10, 2026

Press release

ObvioHealth and SPRIM PRO Launch Integrated Digital Patient Monitoring and Clinical Support Solution for High-Risk Therapies

New strategic offering combines digital health technology with clinical operations and patient support to help pharmaceutical companies modernize patient monitoring for REMS programs and other therapies requiring enhanced clinical oversight.NEW YORK, Sept. 10, 2026 /PRNewswire/ -- The pharmaceutical industry is entering a new era of increasingly specialized therapies that require more intensive patient monitoring beyond the point of care. Specialty medicines have accounted for more than half of

Sep 10, 2026

Press release

MHK and MCG Partner to Connect Evidence-Based Clinical Guidance with Standards-Based Prior Authorization

New integration to help health plans streamline prior authorization and prepare for CMS-0057-F complianceSEATTLE, Sept. 10, 2026 /PRNewswire/ -- MCG Health, part of the Hearst Health network and the industry's source of truth for trusted clinical guidance, announces a newly certified integration with MHK, a leading healthcare technology provider and a sibling Hearst Health company. The new integration connects the MCG Path interoperability solution directly with the MHK CareProminence prior auth

Sep 10, 2026

Press release

New paper highlights the need for integrated digital behavioral support, proposing a "habit window hypothesis" and associated research agenda to maximize the long-term success of GLP-1 therapies

TORONTO, Sept. 10, 2026 /PRNewswire/ -- Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant hurdles for many patients. A new viewpoint paper published in the Journal of Medical Internet Research by JMIR Publications highlights a fundamental challenge: medication alone is not enough to secure long-term behavioral change. In the paper titled "Digital Behavioral Infrastructure for Glucagon-Like Peptide-

Sep 10, 2026

Press release

Inspiren Raises $70M Series C to Scale Physical AI for Senior Living

$225 million raised to date at a valuation exceeding $500 million, funding technology that helps care teams act before resident needs become emergenciesNEW YORK, Sept. 10, 2026 /PRNewswire/ -- Inspiren, the leader in AI-powered solutions redefining senior living, today announced it has raised $70 million in Series C funding at a valuation exceeding $500 million. The round was led by NewView Capital, with participation from Insight Partners, Primary Venture Partners, Scale Venture Partners, Vinta

Sep 10, 2026

Press release

Nearly Half of U.S. Families Cannot Afford Diapers; Experts Tell Congress that Providing Diapers Will Save Tax Dollars

WASHINGTON, Sept. 10, 2026 /PRNewswire/ -- Nearly half of U.S. families struggle to afford enough diapers for their babies (Source: The NDBN Diaper Check 2026), and research demonstrates that changing that will improve public health and save Medicaid dollars, experts will tell members of Congress in a briefing on Tuesday, September 15.Continue Reading The briefing takes place during National Diaper Need Awareness Week (September 14-20), when the National Diaper Bank Network (NDB

Back to start
Previous
Page 18 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Legal